Press Releases April 7, 2026 08:00 PM

Nasdaq Reports March 2026 Volumes and 1Q26 Statistics

Nasdaq releases monthly and quarterly trading volumes and statistics for Q1 2026

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
NDAQ

Nasdaq announced its trading volumes for March 2026 along with quarterly volumes, estimated revenue capture, number of listings, and index statistics for the first quarter ended March 31, 2026. The detailed data is available on Nasdaq's Investor Relations website.

Nasdaq Reports March 2026 Volumes and 1Q26 Statistics
NDAQ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nasdaq reported trading volumes and key market statistics for March 2026 and Q1 2026.
  • The report includes estimated revenue capture, number of listings, and index statistics.
  • Data is accessible through Nasdaq's Investor Relations portal, offering transparency to investors and market participants.

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for March 2026, as well as quarterly volumes, estimated revenue capture, number of listings, and index statistics for the quarter ended March 31, 2026, on its Investor Relations website.

A data sheet showing this information can be found at: https://ir.nasdaq.com/financials/volume-statistics.

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading technology platform that powers the world’s economies. We architect the world’s most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by designing and deploying markets, technology, data, and advanced analytics that enable our clients to capture opportunities, navigate risk, and strengthen resilience. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.

Media Relations Contact:
David Lurie
+1.914.538.0533
[email protected]

Investor Relations Contact:
Ato Garrett
+1.212.401.8737
[email protected]

-NDAQF-


Risks

  • Market volumes and revenue are subject to fluctuations based on overall economic and market conditions.
  • Changes in regulatory policies could impact market operations and Nasdaq's revenue streams.
  • Competition from other exchanges and trading platforms may affect Nasdaq's growth and market share.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026